Related Experiment Videos
A low NM23.H1 gene expression identifying high malignancy human melanomas
M A Caligo1, P Grammatico, G Cipollini
1Institute of Pathology, University of Pisa, Italy.
Melanoma Research
|June 1, 1994
Summary
The NM23 gene, a potential metastasis suppressor, shows lower expression in aggressive melanomas. Higher NM23.H1 gene expression correlates with better disease-free survival in melanoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The NM23 gene is investigated as a potential metastasis-suppressor gene and prognostic factor in cancer.
- Previous studies indicate an inverse relationship between NM23 expression and metastatic ability in murine melanoma cell lines.
- Lower NM23 expression was observed in human malignant melanoma metastases that developed rapidly.
Purpose of the Study:
- To investigate the expression of the NM23.H1 gene in primary and metastatic human malignant melanoma cell lines.
- To correlate NM23.H1 expression with clinical parameters including staging, infiltration, lymphocytic infiltration, cell morphology, pigmentation, karyotype, and disease-free survival.
Main Methods:
- Analysis of NM23.H1 gene mRNA expression levels in established human melanoma cell lines.
- Correlation of gene expression data with patient clinical data and tumor characteristics.
Main Results:
- NM23.H1 mRNA expression was significantly lower in cell lines derived from more infiltrating primary melanomas compared to less infiltrating tumors.
- Cell lines from patients with longer disease-free survival (>24 months) exhibited higher NM23.H1 gene expression than those with shorter survival (<24 months).
Conclusions:
- NM23.H1 gene expression levels are inversely correlated with melanoma invasiveness.
- Higher NM23.H1 expression is associated with a more favorable prognosis and longer disease-free survival in melanoma patients, supporting its role as a prognostic marker.